PMDA
- Application: Taltz
- Local brand name: Taltz
- Status: approved
🇯🇵 Proactive TDM-based dosing of ixekizumab in Japan
Proactive TDM-based dosing of ixekizumab (Proactive TDM-based dosing of ixekizumab) regulatory status in Japan.
Marketing authorisation
Proactive TDM-based dosing of ixekizumab in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Proactive TDM-based dosing of ixekizumab approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for Proactive TDM-based dosing of ixekizumab in Japan?
University Hospital, Ghent is the originator. The local marketing authorisation holder may differ — check the official source linked above.